Following receipt of dupilumab for 24 weeks, desensitization to peanut exposure in most children/adolescents with peanut allergy was not achieved, according to study results. Image: Adobe Stock ...
Hosted on MSN3mon
Kymera's IND Application for STAT6 Degrader Gets FDA ClearanceSanofi SNY and Regeneron’s REGN Dupixent (dupilumab), an injectable monoclonal ... including relapsed/refractory classic Hodgkin’s lymphoma (cHL), cutaneous T-cell lymphoma and NK-cell ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results